Prospective observational study on the use of transmucosal fentanyl citrate in routine clinical practice for the control of breakthrough pain crises in cancer patients
COMMERCIAL POST AUTHORIZATION STUDY
Clinical trial information
- Promoter: FERRER INTERNATIONAL SA
- Execution start: 24/07/2020
- End of execution: 30/09/2020
- IP: ISABEL CASTILLO PEREZ
